Exenatide improves hepatic steatosis by enhancing lipid use in adipose tissue in nondiabetic rats. - Wikidata - awgldk - TriplyDB

Exenatide improves hepatic steatosis by enhancing lipid use in adipose tissue in nondiabetic rats.

Exenatide improves hepatic steatosis by enhancing lipid use in adipose tissue in nondiabetic rats.

http://www.wikidata.org/entity/Q37629687

about

Extended exenatide administration enhances lipid metabolism and exacerbates pancreatic injury in mice on a high fat, high carbohydrate diet Adenosine monophosphate-activated protein kinase-based classification of diabetes pharmacotherapy A(a)LS: Ammonia-induced amyotrophic lateral sclerosis.Effects of Exendin-4 on human adipose tissue inflammation and ECM remodelling.Resveratrol alleviates FFA and CCl4 induced apoptosis in HepG2 cells via restoring endoplasmic reticulum stress.Cooperative role of the glucagon-like peptide-1 receptor and β3-adrenergic-mediated signalling on fat mass reduction through the downregulation of PKA/AKT/AMPK signalling in the adipose tissue and muscle of rats.Exenatide improves both hepatic and adipose tissue insulin resistance: A dynamic positron emission tomography study.

P2860

Q27339590-12A359F3-185B-4F27-B717-77EED27163CC Q28068120-381530C3-FCFA-4EB5-B876-67724BE7BE6C Q37337058-69EB0D99-8010-4532-A9C6-EB43939013C7 Q37575885-56CD6480-E9FD-43B9-B09B-938471F79FB1 Q38834079-6C00C3AF-4A18-45E3-B9A1-93B28B6F37E4 Q47343137-541B21A5-CF4B-4A32-BA09-CC17A6E209AB Q53964243-FF08D7ED-BE7F-46E0-AB7B-1E7103C75185

P2860

Exenatide improves hepatic steatosis by enhancing lipid use in adipose tissue in nondiabetic rats.

http://www.wikidata.org/entity/Q37629687

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Exenatide improves hepatic ste ...... se tissue in nondiabetic rats.

@en

Exenatide improves hepatic ste ...... se tissue in nondiabetic rats.

@nl

type

label

Exenatide improves hepatic ste ...... se tissue in nondiabetic rats.

@en

Exenatide improves hepatic ste ...... se tissue in nondiabetic rats.

@nl

prefLabel

Exenatide improves hepatic ste ...... se tissue in nondiabetic rats.

@en

Exenatide improves hepatic ste ...... se tissue in nondiabetic rats.

@nl

P1433

Q37629687-8A53F1C0-3B66-4BB6-8D8C-57F8A4779F42

P1476

Q37629687-53492A7D-0EAB-48A5-B528-EEC7B9259C10

P2093

Q37629687-00466DF1-8BDD-4A07-8614-12B7FC1939F7

Q37629687-1602739F-806C-4A30-B809-9BBCB8E25B65

Q37629687-1909F374-830C-4C70-B30B-0C8362088BCD

Q37629687-20B8EFAC-DE6F-4669-9D8A-BB5BCC4AA81C

Q37629687-46430601-B46D-41B8-95DE-358C13891DD8

Q37629687-50205C6F-8D5B-4F6C-BA34-3BCE293D89AE

Q37629687-50F66024-3862-414D-96C1-CFA52E78FA99

Q37629687-71B945A8-A1E3-4221-A89F-21A83D063B23

Q37629687-924E6217-3DC6-41A5-911C-84B60D784DE3

Q37629687-DBCD0209-D980-4A67-AF5B-996081697056

P2860

Q37629687-08D5D6E6-342C-435F-A8F4-6746E67FD647

Q37629687-08DA8DE7-899B-4730-BD5B-C4134F4A2BF8

Q37629687-0BF8F316-C3FD-4BAA-987C-E1A3B8F8F303

Q37629687-10E08327-FE24-4601-9B62-90BA3EEF597D

Q37629687-13E9D4D7-24AD-4CE2-9309-0CCC9C044D65

Q37629687-1A0479B3-7B1F-4C0B-B3A4-43C39FCAB341

Q37629687-205A97D5-4939-4A4B-AADA-A8A4C4307C61

Q37629687-20F14A54-A662-42B0-AFF5-F4D692B38D53

Q37629687-28FF4D17-61BA-4EDE-9801-307E6A05FFF5

Q37629687-2EBE2FD6-93D2-417B-9225-72B192CCC9DB

P304

Q37629687-1DB91FAD-AF9F-4DC8-820B-B4236B5AC55E

P31

Q37629687-DBA54447-F089-462B-93E4-FCB7284845C4

P356

Q37629687-7759923B-66FF-496B-AEE6-4C853B913529

P407

Q37629687-1B9A1632-FA2F-4CDF-8FBE-A1F92FC09ECA

P433

Q37629687-397B11DD-5123-4F89-98D1-0DD1ABA9433C

P478

Q37629687-1ABD91DB-734E-4079-B799-7B189BAF8A64

P577

Q37629687-5CB8A472-FABF-4F66-9420-94A5436E6386

P698

Q37629687-5FCC0F57-0E15-42E4-B5EB-CD40C2D40F14

P932

Q37629687-91F42ABF-C541-4050-8342-92661430C404

P356

WJG.V20.I10.2653

P1433

World Journal of Gastroenterology

P1476

Exenatide improves hepatic ste ...... se tissue in nondiabetic rats.

@en

P2093

Kazuhiro Kotoh

http://www.w3.org/2001/XMLSchema#string

Kosuke Tanaka

http://www.w3.org/2001/XMLSchema#string

Makoto Nakamuta

http://www.w3.org/2001/XMLSchema#string

Masaki Kato

http://www.w3.org/2001/XMLSchema#string

Masatake Tanaka

http://www.w3.org/2001/XMLSchema#string

Masatoshi Nomura

http://www.w3.org/2001/XMLSchema#string

Masayuki Miyazaki

http://www.w3.org/2001/XMLSchema#string

Munechika Enjoji

http://www.w3.org/2001/XMLSchema#string

Ryoichi Takayanagi

http://www.w3.org/2001/XMLSchema#string

Toyoshi Inoguchi

http://www.w3.org/2001/XMLSchema#string

P2860

Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice

Treatment of non-alcoholic fatty liver disease

Antioxidant enzymes and human diseases

The Physiology of Glucagon-like Peptide 1

Biology of incretins: GLP-1 and GIP

Exenatide in type 2 diabetes: treatment effects in clinical studies and animal study data.

Nutritional modulation of nonalcoholic fatty liver disease and insulin resistance: human data.

Exendin-4 improves steatohepatitis by increasing Sirt1 expression in high-fat diet-induced obese C57BL/6J mice

Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas.

Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review.

P304

2653-2663

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V20.I10.2653

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24627601

http://www.w3.org/2001/XMLSchema#string

P932

3949274

http://www.w3.org/2001/XMLSchema#string